Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1988 1
1990 1
2015 1
2016 1
2021 2
2022 5
2023 8
2024 12
2025 12
2026 13

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

45 results

Results by year

Filters applied: . Clear all
Page 1
Showing results for F. hourani
Your search for F. Hourali retrieved no results
Allografts in soft-tissue knee surgery.
Al-Hourani K, Haddad FS. Al-Hourani K, et al. Bone Joint J. 2024 Jun 1;106-B(6):516-521. doi: 10.1302/0301-620X.106B6.BJJ-2024-0081.R1. Bone Joint J. 2024. PMID: 38821497 No abstract available.
Metastasis-directed therapy in oligometastatic prostate cancer.
Miszczyk M, Soeterik T, Marra G, Matsukawa A, Shariat SF. Miszczyk M, et al. Curr Opin Urol. 2024 May 1;34(3):178-182. doi: 10.1097/MOU.0000000000001169. Epub 2024 Mar 5. Curr Opin Urol. 2024. PMID: 38426229 Free PMC article. Review.
Toxicities of PARP inhibitors in genitourinary cancers.
Szalontai J, Szarvas T, Miszczyk M, Nyirády P, Shariat SF, Fazekas T. Szalontai J, et al. Curr Opin Urol. 2025 Jul 1;35(4):467-471. doi: 10.1097/MOU.0000000000001297. Epub 2025 May 7. Curr Opin Urol. 2025. PMID: 40336260 Free PMC article. Review.
Prostate radiotherapy in patients with metastatic hormone-sensitive prostate cancer: A systematic review and meta-analysis of randomised controlled trials.
Roessler N, Miszczyk M, Dematteis A, Zattoni F, Fazekas T, Carletti F, Reitano G, Matsukawa A, Alfarhan AR, Cormio A, Alqahtani AS, Soeterik TFW, Marvaso G, Gandaglia G, Nyirády P, Rajwa P, Nyk Ł, Palencia PS, Leapman MS, Jereczek-Fossa BA, Shariat SF. Roessler N, et al. Clin Transl Radiat Oncol. 2025 Jul 5;54:101009. doi: 10.1016/j.ctro.2025.101009. eCollection 2025 Sep. Clin Transl Radiat Oncol. 2025. PMID: 40687731 Free PMC article. Review.
Assessing the Performance of 18F-FDG PET/CT in Bladder Cancer: A Narrative Review of Current Evidence.
Bacchiani M, Salamone V, Massaro E, Sandulli A, Mariottini R, Cadenar A, Di Maida F, Pradere B, Mertens LS, Longoni M, Krajewski W, Del Giudice F, D'Andrea D, Laukhtina E, Shariat SF, Minervini A, Moschini M, Mari A, On Behalf Of European Association Of Urology-Young Academic Urologists Eau-Yau Urothelial Carcinoma Working Group. Bacchiani M, et al. Cancers (Basel). 2023 May 28;15(11):2951. doi: 10.3390/cancers15112951. Cancers (Basel). 2023. PMID: 37296913 Free PMC article. Review.
RESULTS: Twenty-three studies met the inclusion criteria: fourteen studies evaluated 18F-FDG PET/CT for nodal staging, six studies examined its accuracy for restaging after neoadjuvant therapy, and three studies evaluated both applications. To date, the use of F-18 FDG PET …
RESULTS: Twenty-three studies met the inclusion criteria: fourteen studies evaluated 18F-FDG PET/CT for nodal staging, six studies examined …
Side effect management and procedural best practices with indwelling intravesical drug-releasing systems in the treatment of bladder cancer: recommendations from expert panels.
Pradere B, Schuit M, Guerrero-Ramos F, Shariat SF, Kitamura H, Jacob JM, Bao Y, Heesakkers J, Peters KM, Cahn DJ, De Troyer B, Herrera Imbroda B, Morris DS, Pieczonka CM, Wei Q, Bhanvadia S, Somer R, Jessner W, Triantos S, Sánchez de Llano C, Maffeo JC, Sweiti H, Psutka SP. Pradere B, et al. Curr Opin Urol. 2026 Jan 1;36(1):123-133. doi: 10.1097/MOU.0000000000001350. Epub 2025 Oct 7. Curr Opin Urol. 2026. PMID: 41065373 Free PMC article. Review.
Central Nervous System Toxicity in Prostate Cancer Patients Treated with Androgen Receptor Signaling Inhibitors: A Systematic Review, Meta-analysis, and Network Meta-analysis.
Matsukawa A, Yanagisawa T, Rajwa P, Fazekas T, Miszczyk M, Tsuboi I, Parizi MK, Laukhtina E, Klemm J, Chiujdea S, Mancon S, Mori K, Kimura S, Karakiewicz PI, Miki J, Kimura T, Shariat SF. Matsukawa A, et al. Clin Genitourin Cancer. 2025 Feb;23(1):102251. doi: 10.1016/j.clgc.2024.102251. Epub 2024 Oct 24. Clin Genitourin Cancer. 2025. PMID: 39571519 Free article.
Sequencing impact and prognostic factors in metastatic castration-resistant prostate cancer patients treated with cabazitaxel: A systematic review and meta-analysis.
Yanagisawa T, Kawada T, Rajwa P, Mostafaei H, Motlagh RS, Quhal F, Laukhtina E, König F, Pallauf M, Pradere B, Karakiewicz PI, Nyirady P, Kimura T, Egawa S, Shariat SF. Yanagisawa T, et al. Urol Oncol. 2023 Apr;41(4):177-191. doi: 10.1016/j.urolonc.2022.06.018. Epub 2022 Aug 13. Urol Oncol. 2023. PMID: 35970698 Free article.
45 results